Capital World Investors’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-238,020
| Closed | -$23.1M | – | 560 |
|
|
2019
Q3 | $23.1M | Hold |
238,020
| – | – | 0.01% | 395 |
|
|
2019
Q2 | $24.4M | Hold |
238,020
| – | – | 0.01% | 417 |
|
|
2019
Q1 | $27.1M | Hold |
238,020
| – | – | 0.01% | 402 |
|
|
2018
Q4 | $9.32M | Hold |
238,020
| – | – | ﹤0.01% | 477 |
|
|
2018
Q3 | $13M | Sell |
238,020
-108,000
| -31% | -$7.39M | ﹤0.01% | 496 |
|
|
2018
Q2 | $28.6M | Hold |
346,020
| – | – | 0.01% | 426 |
|
|
2018
Q1 | $23M | Hold |
346,020
| – | – | 0.01% | 420 |
|
|
2017
Q4 | $17.8M | Hold |
346,020
| – | – | ﹤0.01% | 440 |
|
|
2017
Q3 | $30.9M | Hold |
346,020
| – | – | 0.01% | 389 |
|
|
2017
Q2 | $20.7M | Sell |
346,020
-113,500
| -25% | -$6.34M | ﹤0.01% | 422 |
|
|
2017
Q1 | $24.5M | Buy |
459,520
+31,500
| +7% | +$1.87M | 0.01% | 404 |
|
|
2016
Q4 | $21.4M | Buy |
428,020
+25,000
| +6% | +$1.34M | 0.01% | 396 |
|
|
2016
Q3 | $24.2M | Hold |
403,020
| – | – | 0.01% | 387 |
|
|
2016
Q2 | $20.6M | Hold |
403,020
| – | – | 0.01% | 396 |
|
|
2016
Q1 | $11.9M | Sell |
403,020
-150,000
| -27% | -$4.73M | ﹤0.01% | 436 |
|
|
2015
Q4 | $25.1M | Buy |
553,020
+150,000
| +37% | +$7.86M | 0.01% | 406 |
|
|
2015
Q3 | $16.8M | Buy |
403,020
+45,000
| +13% | +$2.35M | ﹤0.01% | 441 |
|
|
2015
Q2 | $21.6M | Hold |
358,020
| – | – | 0.01% | 433 |
|
|
2015
Q1 | $27.7M | Buy |
+358,020
| New | +$20.6M | 0.01% | 417 |
|
Capital World Investors's ONCE Position: Q4 2019 in Review
Capital World Investors sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 238,020 shares — an estimated $23.1M sold.
Capital World Investors first reported a position in ONCE in Q1 2015 and held it in 19 quarters. The position peaked at $30.9M in Q3 2017. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.
- Capital World Investors reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
- Capital World Investors sold 238,020 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $23.1M.
- Capital World Investors first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 19 quarters.
- Capital World Investors's Spark Therapeutics, Inc. Common Stock position peaked at $30.9M in Q3 2017.
- 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.
Based on Capital World Investors's 13F filing for Q4 2019, filed 18 Feb 2020.